Jubilant Life Sciences Ltd Net Profit is INR 309.93 crores in Q3 FY 2020-2021

Jubilant Life Sciences Ltd Q3 FY20-21 Quarter Result

Jubilant Life Sciences Ltd Net Profit is INR 309.93 crores in Quarter 3, October – December of Financial Year 2020-2021.

Quarterly Net Earnings Year-on-Year

Jubilant Life Sciences Ltd Quarter Net Profit is Up by 52 % from Last Year Quarter and Net Profit of INR 309.93 crores is reported in Quarter 3, October – December of Financial Year 2020-2021. Last Year Quarter 3, October – December of Financial Year 2019-2020 Net Profit was INR 203.38 crores.

Quarterly Net Sales Year-on-Year

Jubilant Life Sciences Ltd Quarter Sale is up 17 % from Last Quarter. Sales of 1771.34 is reported in Quarter 3, October – December of Financial Year 2020-2021. In Last Year Quarter 3, October – December of Financial Year 2019-2020 Sale was 1517.98

Annual Sales & Net Earning

Jubilant Life Sciences Ltd Annual Sales in Financial Year 2019 to 2020 was reported INR 9110.82 crores and Annual Profit in Financial Year 2019 to 2020 was reported INR 574.46 crores.


Jubilant Life Sciences Ltd Stock Information

SectorPharmaceuticals
IndustryPharmaceuticals – Indian – Bulk Drugs
AboutJubilant Life Sciences,is an integrated global pharmaceutical and life sciences company engaged in manufacturing and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products, Advance Intermediates, Fine Ingredients, Crop Science Ingredients, Life Science Chemicals and Nutritional Products.
Latest Qaurter EPS19.455740497232078

Jubilant Life Sciences Ltd Stock Analysis:

Get more Quarterly Earnings Results of companies

Get complete data on Jubilant Life Sciences Ltd

Leave a Comment

Your email address will not be published. Required fields are marked *